Instem Picks up BioWisdom for $2.4M to Expand Drug Development Data-Management Offerings

Instem, which is based in Staffordshire, UK, and employs just over 100 people worldwide, acquired the 13-person BioWisdom to add new information-extraction capabilities to its current drug development software tools.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.